Oshinomi Kazuhiko, Kikuchi Shota, Kishi Hirotaka, Hayashi Anju, Okada Sho, Kurokawa Masahiro, Mugita Toshiki, Inoue Tatsuki, Yamagishi Motoki, Nakagami Yoshihiro, Nagata Masakazu, Fukagai Takashi
Department of Urology, Showa University School of Medicine, Tokyo, Japan.
Cancer Diagn Progn. 2025 May 3;5(3):313-318. doi: 10.21873/cdp.10443. eCollection 2025 May-Jun.
BACKGROUND/AIM: Robot-assisted radical prostatectomy (RARP) outcomes improve with surgical experience, but preoperative prediction of disease stage is crucial to avoid unexpected T stage upgrades, such as pT3b. This study aimed to identify preoperative predictive factors for pT3b (seminal vesicle invasion) following RARP.
Out of 299 RARP performed between 2013 and 2020, 246 cases without preoperative hormone therapy were included. Of these, 19 cases (7.7%) were pT3b. T classification was performed using magnetic resonance imaging (MRI), and 12-site prostate biopsies were conducted. Cox proportional hazards, logistic regression analysis, and Kaplan-Meier analyses were used.
The 3-year prostate specific antigen (PSA) recurrence-free survival rate was 87% but significantly lower at 70% for pT3b cases. Multivariate logistic regression analysis identified the International Society of Urological Pathology (ISUP) grade group at biopsy as the only significant preoperative predictor of pT3b.
pT3b is associated with increased postoperative biochemical recurrence risk, and ISUP grade group at biopsy serves as a significant preoperative predictive factor for pT3b.
背景/目的:机器人辅助根治性前列腺切除术(RARP)的手术效果会随着手术经验的增加而改善,但术前对疾病分期的预测对于避免意外的T分期升级(如pT3b)至关重要。本研究旨在确定RARP术后pT3b(精囊侵犯)的术前预测因素。
在2013年至2020年期间进行的299例RARP手术中,纳入246例未接受术前激素治疗的病例。其中,19例(7.7%)为pT3b。使用磁共振成像(MRI)进行T分期,并进行12位点前列腺活检。采用Cox比例风险模型、逻辑回归分析和Kaplan-Meier分析。
3年无前列腺特异性抗原(PSA)复发生存率为87%,但pT3b病例显著降低至70%。多变量逻辑回归分析确定活检时的国际泌尿病理学会(ISUP)分级组是pT3b唯一显著的术前预测因素。
pT3b与术后生化复发风险增加相关,活检时的ISUP分级组是pT3b显著的术前预测因素。